Seasonal variation in blood drug concentrations and a potential relationship to Vitamin D

Drug Metabolism and Disposition

Volumn 39, Issue 5, 2011, Pages 933-937

  Lindh, Jonatan D ^a   Andersson, Marine L ^a   Eliasson, Erik ^a   Björkhem Bergman, Linda ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYTOCHROME P450 3A4; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS; VITAMIN D;

ARTICLE; CROSS REACTION; DRUG BLOOD LEVEL; DRUG METABOLISM; IMMUNOASSAY; PRIORITY JOURNAL; SEASONAL VARIATION; ULTRAVIOLET RADIATION;

CYTOCHROME P-450 CYP3A; DATABASES, FACTUAL; DRUG MONITORING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; SEASONS; SUNLIGHT; ULTRAVIOLET RAYS; VITAMIN D; VITAMINS;

EID: 79955043225     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.111.038125     Document Type: Article

References (23)

1. Burgaz A, Akesson A, Michaëlsson K, and Wolk A (2009) 25-Hydroxyvitamin D accumulation during summer in elderly women at latitude 60 degrees N. J Intern Med 266:476-483.
2. Christensen MH, Lien EA, Hustad S, and Almås B (2010) Seasonal and age-related differences in serum 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone in patients from Western Norway. Scand J Clin Lab Invest 70:281-286.
3. Daly AK (2006) Significance of the minor cytochrome P450 3A isoforms. Clin Pharmacokinet 45:13-31. (Pubitemid 43145013)
4. Evans WE and Relling MV (1999) Pharmacogenomics: Translating functional genomics into rational therapeutics. Science 286:487-491.
5. Fan J, Liu S, Du Y, Morrison J, Shipman R, and Pang KS (2009) Up-regulation of transporters and enzymes by the vitamin D receptor ligands, 1alpha,25-dihydroxyvitamin D3 and vitamin D analogs, in the Caco-2 cell monolayer. J Pharmacol Exp Ther 330:389-402.
6. Finch PJ, Ang L, Colston KW, Nisbet J, and Maxwell JD (1992) Blunted seasonal variation in serum 25-hydroxy vitamin D and increased risk of osteomalacia in vegetarian London Asians. Eur J Clin Nutr 46:509-515.
7. Fulton B and Markham A (1996) Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation. Drugs 51:278-298.
8. Heaney RP, Armas LA, Shary JR, Bell NH, Binkley N, and Hollis BW (2008) 25-Hydroxylation of vitamin D3: Relation to circulating vitamin D3 under various input conditions. Am J Clin Nutr 87:1738-1742. (Pubitemid 351872637)
9. Iwasaki K (2007) Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics. Drug Metab Pharmacokinet 22:328-335.
10. Lampen A, Christians U, Bader A, Hackbarth I, and Sewing KF (1996) Drug interactions and interindividual variability of ciclosporin metabolism in the small intestine. Pharmacology 52:159-168. (Pubitemid 26076283)
11. Lampen A, Christians U, Guengerich FP, Watkins PB, Kolars JC, Bader A, Gonschior AK, Dralle H, Hackbarth I, and Sewing KF (1995) Metabolism of the immunosuppressant tacrolimus in the small intestine: Cytochrome P450, drug interactions, and interindividual variability. Drug Metab Dispos 23:1315-1324. (Pubitemid 26007838)
12. Lampen A, Zhang Y, Hackbarth I, Benet LZ, Sewing KF, and Christians U (1998) Metabolism and transport of the macrolide immunosuppressant sirolimus in the small intestine. J Pharmacol Exp Ther 285:1104-1112. (Pubitemid 28277909)
13. Landin-Wilhelmsen K, Wilhelmsen L, Wilske J, Lappas G, Rosín T, Lindstedt G, Lundberg PA, and Bengtsson BA (1995) Sunlight increases serum 25(OH) vitamin D concentration whereas 1,25(OH)2D3 is unaffected. Results from a general population study in Göteborg, Sweden (The WHO MONICA Project). Eur J Clin Nutr 49:400-407.
14. Lo A and Burckart GJ (1999) P-Glycoprotein and drug therapy in organ transplantation. J Clin Pharmacol 39:995-1005. (Pubitemid 30641858)
15. Lund B and Sørensen OH (1979) Measurement of 25-hydroxyvitamin D in serum and its relation to sunshine, age and vitamin D intake in the Danish population. Scand J Clin Lab Invest 39:23-30. (Pubitemid 10136889)
16. Mirghani RA, Sayi J, Aklillu E, Allqvist A, Jande M, Wennerholm A, Eriksen J, Herben VM, Jones BC, Gustafsson LL, et al. (2006) CYP3A5 genotype has significant effect on quinine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity than a Swedish population. Pharmacogenet Genomics 16:637-645. (Pubitemid 44223075)
17. Negoro S, Izumi S, Furukubo T, Satoh M, Matsunaga C, Yamakawa T, Ikegawa S, Nakanishi H, Kadowaki D, and Hirata S (2007) Interaction between activated VD3 and Ca channel blockers in patients undergoing hemodialysis. Int J Clin Pharmacol Ther 45:186-187. (Pubitemid 46416087)
18. Qiu H, Mathäs M, Nestler S, Bengel C, Nem D, Gödtel-Armbrust U, Lang T, Taudien S, Burk O, and Wojnowski L (2010) The unique complexity of the CYP3A4 upstream region suggests a nongenetic explanation of its expression variability. Pharmacogenet Genomics 20:167-178.
19. Saeki T, Ueda K, Tanigawara Y, Hori R, and Komano T (1993) Human P-glycoprotein transports cyclosporin A and FK506. J Biol Chem 268:6077-6080. (Pubitemid 23099291)
20. Schmiedlin-Ren P, Thummel KE, Fisher JM, Paine MF, Lown KS, and Watkins PB (1997) Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrixcoated permeable supports in the presence of 1α,25 -dihydroxyvitamin D3. Mol Pharmacol 51:741-754. (Pubitemid 27224679)
21. Staatz CE, Goodman LK, and Tett SE (2010) Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I. Clin Pharmacokinet 49:141-175.
22. Stettin M, Halwachs-Baumann G, Genser B, Frühwirth F, März W, and Khoschsorur GA (2006) Determination of cyclosporine A in whole blood: Comparison of a chromatographic method with three different immunological methods. Talanta 69:1100-1105. (Pubitemid 43866159)
23. Virtanen JK, Nurmi T, Voutilainen S, Mursu J, and Tuomainen TP (2010) Association of serum 25-hydroxyvitamin D with the risk of death in a general older population in Finland. Eur J Nutr doi:10.1007/s00394-010-0138-3.